Novozymes acquires German microbial research company Organobalance

Novozymes Headquarter
Novozymes Headquarter

Novozymes, Danish biotech giant, today announced the acquisition of microbial research company Organobalance GmbH for an undisclosed amount. Germany-based Organobalance owns a large collection of microbial strains, some of which date back to the 1920s, and has strong capabilities in microbial screening and assay technology. It specializes in developing natural microbial solutions for customers and partners across a number of industries including food, feed, and animal health.

Continue reading